At a glance
ClinicalIndex Comparison RecordN/ACompleted· 458 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Can Venous Lactate Predict the Progression to Overt Septic Shock and Mortality in Non-elderly Sepsis Patients Without Hemodynamic Shock in Emergency Department?
In Brief
An observational study for Sepsis and 3 related conditions. Completed, enrolled 458 participants across 1 site.
Detailed Summary
To investigate the role of initial venous lactate in predicting the severity progression to overt septic shock and 30-day mortality in non-elderly patients without hemodynamic shock who suspected to have acute infections.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsSepsis, Disease Progression, Septic Shock, Fatal Outcome
CountriesThailand
Collaborators--
Timeline
N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartMar 2013
First PostedSep 2013
Primary CompletionNov 2014
Study CompletionJan 2015
TodayJul 2026
First PostedSep 20, 2013
Enrollment StartMar 1, 2013
Primary CompletionNov 1, 2014
Study CompletionJan 1, 2015
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 12.8 years ago